Thomas Evans | Vaccitech | United Kingdom

Thomas Evans, , Vaccitech

Dr. Thomas G. Evans received his MD from the University of Virginia and trained in Internal Medicine at UCSF, and in Infectious Diseases back at Virginia. He established a laboratory during his first position at the University of Utah and directed the HIV clinic. He moved to the University of Rochester as Associate Professor for 5 years, before becoming Infectious Diseases Division Chief and tenured full Professor at the University of California, Davis. His academic research centered on leishmania and HIV vaccine development and led to him joining Vical, a DNA vaccine developer as Chief Medical Officer in 2002. In 2005 he joined the Novartis Institutes for Biomedical Research as Global Head of Infectious Diseases Translational Medicine and Research. In September 2008 he moved to Shanghai as VP for Translational Sciences in Asia for Novartis. In September 2010 he joined Aeras, a non-profit Product Development Partnership with a mission to develop global tuberculosis vaccines, as the Chief Scientific Officer, and became CEO in February 2013. He joined Vaccitech in the spring of 2016. He has over 140 authored publications. La


Oct 29th Day 1 @ 16:30

New flu data towards a universal flu vaccine

last published: 16/Sep/19 14:05 GMT

back to speakers

Sign Up for Event Updates